Mon, November 8, 2021

Jason Butler Maintained (ABUS) at Buy with Increased Target to $9 on, Nov 8th, 2021

Jason Butler of JMP Securities, Maintained "Arbutus Biopharma Corporation" (ABUS) at Buy with Increased Target from $7 to $9 on, Nov 8th, 2021.

Jason, nor any peers, have made any analyst calls on ABUS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30